US equities
|
MU
$1,035.38
▼-4.84%
NVDA
$230.34
▼-3.00%
SNDK
$1,589.79
▼-6.06%
AMD
$616.30
▼-4.58%
INTC
$106.87
▼-5.53%
SPCX
$161.57
▼-3.59%
META
$719.83
▼-0.21%
MSFT
$521.69
▼-1.52%
MU
$1,035.38
▼-4.84%
NVDA
$230.34
▼-3.00%
SNDK
$1,589.79
▼-6.06%
AMD
$616.30
▼-4.58%
INTC
$106.87
▼-5.53%
SPCX
$161.57
▼-3.59%
META
$719.83
▼-0.21%
MSFT
$521.69
▼-1.52%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Quoin Pharmaceuticals, Inc.
REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
October 24, 2023
From
Quoin Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
QNRX